CRP and atrial fibrillation: Though not traditionally used for rate or rhythm control, atorvastatin may play a preventative role by attenuating systemic inflammation, as evidenced by its ability to lower C-reactive protein (CRP) levels, an inflammatory marker associated with increased risk of AF [52].